AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2021
Mar 3, 2021
29745_dirs_2021-03-03_f0c9e425-b35a-4b91-9e16-400a9d0f0c2b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2021-03-01
Reporting Person: Hakim Anat (SVP, GC & Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-01 | Common Stock | M | 7928 | — | Acquired | 7928 | Direct |
| 2021-03-01 | Common Stock | F | 3493 | $204.89 | Disposed | 4435 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-01 | Restricted Stock Unit | $ | M | 7928 | Disposed | Common Stock (7928.0) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
F2: The Restricted Stock Units vest in two installments, 7,928 on March 1, 2021 and 7,929 on March 1, 2022.
More from ELI LILLY & Co
Regulatory Filings
2026
May 11
Prospectus
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Prospectus
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 20